Learn data and recommendations for HIV postexposure prophylaxis, including currently recommended regimens, single tablet regimens, and PrEP following PEP.
Michelle D. Collins-Ogle, MD, FAAP, FPIDS, AAHIVS
Format: Microsoft PowerPoint (.ppt)
File Size: 184 KB
Released: April 29, 2022
Acknowledgements
Educational grant provided by:
Gilead Sciences, Inc.
Janssen Therapeutics, Division of Janssen Products, LP
ViiV Healthcare
Leaving the CCO site
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.
